These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28259623)

  • 1. Oral and nasal microbiota in Parkinson's disease.
    Pereira PAB; Aho VTE; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
    Parkinsonism Relat Disord; 2017 May; 38():61-67. PubMed ID: 28259623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
    Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
    Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut, oral and nasal microbiota and Parkinson's disease.
    Shen L
    Microb Cell Fact; 2020 Feb; 19(1):50. PubMed ID: 32103766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota are related to Parkinson's disease and clinical phenotype.
    Scheperjans F; Aho V; Pereira PA; Koskinen K; Paulin L; Pekkonen E; Haapaniemi E; Kaakkola S; Eerola-Rautio J; Pohja M; Kinnunen E; Murros K; Auvinen P
    Mov Disord; 2015 Mar; 30(3):350-8. PubMed ID: 25476529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
    Bedarf JR; Hildebrand F; Coelho LP; Sunagawa S; Bahram M; Goeser F; Bork P; Wüllner U
    Genome Med; 2017 Apr; 9(1):39. PubMed ID: 28449715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of the Western Diet and Oral Microbiota in Parkinson's Disease.
    Zapała B; Stefura T; Milewicz T; Wątor J; Piwowar M; Wójcik-Pędziwiatr M; Doręgowska M; Dudek A; Jania Z; Rudzińska-Bar M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.
    Mihaila D; Donegan J; Barns S; LaRocca D; Du Q; Zheng D; Vidal M; Neville C; Uhlig R; Middleton FA
    PLoS One; 2019; 14(6):e0218252. PubMed ID: 31247001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease.
    Pal G; Ramirez V; Engen PA; Naqib A; Forsyth CB; Green SJ; Mahdavinia M; Batra PS; Tajudeen BA; Keshavarzian A
    NPJ Parkinsons Dis; 2021 Dec; 7(1):111. PubMed ID: 34880258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota in patients with Parkinson's disease in southern China.
    Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
    Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaching the Gut and Nasal Microbiota in Parkinson's Disease in the Era of the Seed Amplification Assays.
    Consonni A; Miglietti M; De Luca CMG; Cazzaniga FA; Ciullini A; Dellarole IL; Bufano G; Di Fonzo A; Giaccone G; Baggi F; Moda F
    Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
    Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
    Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
    Li Z; Lu G; Luo E; Wu B; Li Z; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Qiu X; Zheng X; Cai Q; Xu Y; Chen Y; Fan Y; Chen W; Yu Z; Chen X; Zheng C; Wang M; Poon WS; Luo X
    Neuroscience; 2022 Jan; 480():65-78. PubMed ID: 34695538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
    Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
    J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
    Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
    Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of nasal microbiota and its interaction with surface microbiota among residents in healthcare institutes.
    Chen CH; Liou ML; Lee CY; Chang MC; Kuo HY; Chang TH
    Sci Rep; 2019 Apr; 9(1):6175. PubMed ID: 30992494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
    Li W; Wu X; Hu X; Wang T; Liang S; Duan Y; Jin F; Qin B
    Sci China Life Sci; 2017 Nov; 60(11):1223-1233. PubMed ID: 28536926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.
    Nuzum ND; Loughman A; Szymlek-Gay EA; Hendy A; Teo WP; Macpherson H
    Neurosci Biobehav Rev; 2020 May; 112():227-241. PubMed ID: 32032654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Factors That Impact the Oral Microbiota in Parkinson's Disease.
    Rozas NS; Tribble GD; Jeter CB
    Microorganisms; 2021 Jul; 9(8):. PubMed ID: 34442695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-CNS pathogenic origin of Parkinson's disease.
    Choudhry H; Perlmuter LC
    J Neurol; 2017 Sep; 264(9):2027-2030. PubMed ID: 28808780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression.
    Aho VTE; Pereira PAB; Voutilainen S; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
    EBioMedicine; 2019 Jun; 44():691-707. PubMed ID: 31221587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.